P772: LONG-TERM RAVULIZUMAB TREATMENT IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PNH PROVIDES DURABLE CONTROL OF INTRAVASCULAR HEMOLYSIS WITH LOW INCIDENCE OF MAJOR ADVERSE VASCULAR EVENTS AND DEATH.

Detalles Bibliográficos
Autores principales: Kulasekararaj, Austin, Brodsky, Robert, Griffin, Morag, Röth, Alexander, Piatek, Caroline, Ogawa, Masayo, Yu, Ji, Patel, Yogesh, Fernandez, Fernando Ataulfo Gonzalez, Nishimura, Jun-Ichi, Peffault de Latour, Régis, Szer, Jeff, Wook Lee, Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430716/
http://dx.doi.org/10.1097/01.HS9.0000969992.63273.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430716/
http://dx.doi.org/10.1097/01.HS9.0000969992.63273.36

Ejemplares similares